Literature DB >> 32920088

Osteoprotective effect of green tea polyphenols and annatto-extracted tocotrienol in obese mice is associated with enhanced microbiome vitamin K2 biosynthetic pathways.

Moamen M Elmassry1, Eunhee Chung2, Jay J Cao3, Abdul N Hamood4, Chwan-Li Shen5.   

Abstract

The role of the gut microbiome in bone health has received significant attention in the past decade. We investigated the effects of green tea polyphenols (GTP) and annatto-extracted tocotrienols (AT) on bone properties and gut microbiome in obese mice. Male mice were assigned to a two (no AT vs. 400 mg/kg diet AT) × two (no GTP vs. 0.5% w/v GTP) factorial design, namely control, G, T, and G+T group respectively, for 14 weeks. The 4th lumbar vertebra (LV-4) and femur were harvested for bone microstructural analysis using μ-CT. Microbiome analysis using 16S rRNA gene sequencing of cecal feces was performed. AT increased bone volume at distal femur. GTP increased serum procollagen type 1 N-terminal propeptide concentration, bone volume at the distal femur and the LV-4, and trabecular number at distal femur; whereas GTP decreased trabecular separation at distal femur. Interactions between GTP and AT were observed in serum C-terminal telopeptide of type I collagen level (control>G=T=G+T) as well as the cortical bone area (control<G=T=G+T) and thickness (T≥G+T≥G≥control) at femur mid-diaphysis. Redundancy analysis showed a significant difference in the gut microbiome profile among different groups and the relative abundance of Akkermansia muciniphila, Clostridum saccharogumia, and Subdoligranulum variabile was increased in the GTP- and AT-supplemented groups. Functional profiling of the gut microbiome showed the combination of GTP and AT induced biosynthetic pathways for vitamin K2. Our results suggest that GTP and AT supplementation benefits bone properties in obese mice through modifying gut microbiome composition and function.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone health; Green tea; Gut microbiome; Obesity; Vitamin E

Mesh:

Substances:

Year:  2020        PMID: 32920088     DOI: 10.1016/j.jnutbio.2020.108492

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  7 in total

Review 1.  Revisiting the therapeutic potential of tocotrienol.

Authors:  Ranmali Ranasinghe; Michael Mathai; Anthony Zulli
Journal:  Biofactors       Date:  2022-06-20       Impact factor: 6.438

Review 2.  New Advances in Improving Bone Health Based on Specific Gut Microbiota.

Authors:  Qihui Yan; Liping Cai; Weiying Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-07-04       Impact factor: 6.073

Review 3.  Green Tea and Its Relation to Human Gut Microbiome.

Authors:  Sergio Pérez-Burillo; Beatriz Navajas-Porras; Alicia López-Maldonado; Daniel Hinojosa-Nogueira; Silvia Pastoriza; José Ángel Rufián-Henares
Journal:  Molecules       Date:  2021-06-26       Impact factor: 4.411

4.  Gut Microbiota Bacterial Species Associated with Mediterranean Diet-Related Food Groups in a Northern Spanish Population.

Authors:  Carles Rosés; Amanda Cuevas-Sierra; Salvador Quintana; José I Riezu-Boj; J Alfredo Martínez; Fermín I Milagro; Anna Barceló
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

5.  Relationship between Regular Green Tea Intake and Osteoporosis in Korean Postmenopausal Women: A Nationwide Study.

Authors:  Dan Bi Lee; Hong Ji Song; Yu-Jin Paek; Kyung Hee Park; Young-Gyun Seo; Hye-Mi Noh
Journal:  Nutrients       Date:  2021-12-26       Impact factor: 5.717

Review 6.  The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets.

Authors:  Tatsuro Hagi; Clara Belzer
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-14       Impact factor: 4.813

7.  The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.

Authors:  Xue-Jun Kong; Kevin Liu; Patrick Zhuang; Ruiyi Tian; Siyu Liu; Cullen Clairmont; Xiaojing Lin; Hannah Sherman; Junli Zhu; Yelan Wang; Michelle Fong; Alice Li; Bryan K Wang; Jinghan Wang; Zhehao Yu; Chen Shen; Xianghua Cui; Hanyu Cao; Ting Du; Guobin Wan; Xia Cao
Journal:  Probiotics Antimicrob Proteins       Date:  2021-06-11       Impact factor: 4.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.